25 2nd NE St, Aitkin, MN 56431-1419
This exceptional investment opportunity presents a single-tenant, freestanding CVS Pharmacy located at 25 2nd St NE, Aitkin, MN 56431. The property boasts 8,789 square feet of net rentable space, built in 2007, and sits on a single story building. Currently operating at 100% occupancy, the property offers a substantial net operating income (NOI) of $127,000, translating to a compelling 6.15% cap rate. The asking price is $2,065,041. The lease with CVS, an investment-grade tenant (S&P: BBB), has a remaining term of 10 years, providing significant long-term stability. The lease structure includes favorable option terms: six 5-year options with a 10% rent increase in the first option and 5% increases thereafter. CVS has occupied this location since 2013, demonstrating a strong commitment to the site. This location benefits from its proximity to Riverwood Healthcare Center and is situated within a dense retail corridor alongside other national brands such as McDonald's, Subway, Dairy Queen, and Family Dollar. The property enjoys a significant competitive advantage as the only national brand drugstore chain within a 29-mile radius. This is a rare opportunity to acquire a high-performing, investment-grade retail property with substantial long-term growth potential.
-
CVS Pharmacy
-
CVS Photo (Bike/Boat/Book/etc) Store
-
LibertyX Bitcoin ATM Atm
-
CDReload - Online Bitcoin ATM Atm Crypto Atm
-
CDReload Instant Bitcoin Crypto Atm
Cap rate
Implied · in-place · derived from last sale + estimated NOIValue
AI, CAP & Alternative Use estimations · Realmo proprietary blendProperty tax & assessments
Tax year 2023Comparables
6 recent transactions · within 1.5 miComparable in this City
Similar Nearby for Sale
Property description
Physical attributes from public recordsZoning & alternative use
No recorded transactions found for this property.
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.